What is BPC-157? A Researcher's Guide to the Gastric Pentadecapeptide

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. It has attracted significant research interest due to its apparent pleiotropic effects across multiple tissue types, particularly in the context of tissue repair, angiogenesis, and gastrointestinal protection.

This guide covers what BPC-157 is, how it works mechanistically, and why it remains one of the most actively researched peptides in regenerative biology.

What is BPC-157?

BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV) derived from the BPC protein isolated from human gastric juice. It is stable in human gastric juice and has demonstrated activity in both systemic and local administration models across a wide range of preclinical studies.

Unlike many research peptides, BPC-157 does not act through a single well-defined receptor pathway — its effects appear to be mediated through multiple mechanisms including nitric oxide (NO) system modulation, growth factor upregulation, and direct cellular signalling.

Mechanism of Action

BPC-157’s mechanisms of action are multifactorial and continue to be an active area of investigation. Key pathways studied include:

• Nitric oxide (NO) system — BPC-157 appears to modulate NO production, which plays a role in vasodilation, tissue perfusion, and wound healing
• Growth factor upregulation — studies suggest BPC-157 may upregulate VEGF and other growth factors involved in angiogenesis and tissue repair
• Tendon and ligament fibroblast activity — preclinical data indicates enhanced collagen synthesis and fibroblast proliferation in musculoskeletal tissue models
• Gastrointestinal cytoprotection — consistent with its gastric origin, BPC-157 has demonstrated protective effects in GI tract injury models

Why BPC-157 is of Research Interest

BPC-157 has one of the broadest preclinical research profiles of any synthetic peptide, with studies spanning multiple organ systems. Key areas of ongoing research include:

• Tendon, ligament, and muscle repair models
• Gastrointestinal injury and inflammatory bowel disease models
• Bone healing and fracture repair
• Neurological injury and neuroprotection
• Angiogenesis and wound healing
• Systemic organ protection models

BPC-157 vs. BPC-157 + TB-500 Blend

BPC-157 is frequently studied alongside TB-500 (Thymosin Beta-4) due to their complementary mechanisms:

• BPC-157 — primarily studied for local tissue repair, GI protection, and angiogenesis
• TB-500 — primarily studied for actin regulation, cell migration, and systemic tissue repair
• BPC-157 + TB-500 Blend — used in research models investigating combined or synergistic repair mechanisms

Sourcing BPC-157 for Research

Research-grade BPC-157 should be sourced from suppliers providing batch-specific Certificates of Analysis (CoA) confirming purity (>98%), identity, and potency. Lyophilised formats offer optimal stability for laboratory storage.

At Aura Peptides, our BPC-157 is supplied as a research-grade lyophilised peptide with full CoA documentation, available as single vials or in 10x bulk packs for high-volume research programmes.

For research purposes only. Not intended for human or veterinary use.